|
시장보고서
상품코드
2055047
케타민 클리닉 시장 : 치료법별, 임상 적응별, 투여 경로별, 환자 연령층별, 케어 유형별, 소개 경로별, 비즈니스 모델별, 지역별Ketamine Clinic Market, By Therapy Modality, By Clinical Indication, By Route of Administration, By Patient Age Group, By Care Type, By Referral Channel, By Business Model, By Geography |
||||||
케타민 클리닉 시장은 2026년에 16억 달러로 추정되며, 2033년까지 34억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 11.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 16억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.40% | 2033년 시장 규모 예측 : | 34억 2,000만 달러 |
세계 케타민 클리닉 시장은 정신 건강 및 통증 관리 분야에서 급속히 성장하고 있는 부문으로, 다양한 치료 용도를 위해 케타민 기반 치료를 제공하는 전문 의료시설이 특징입니다. 이 클리닉들은 주로 치료 저항성 우울증, 만성 통증, 외상 후 스트레스 장애(PTSD), 불안 장애, 그리고 기존 치료법으로는 효과가 부족한 것으로 밝혀진 기타 신경정신과적 질환에 대해 케타민 정맥 주사 요법을 제공하는 데 중점을 두고 있습니다. 케타민이 N-메틸-D-아스파르트산(NMDA) 수용체 길항제로서 지닌 독특한 작용기전이 신속한 항우울 효과와 진통 작용을 가져온다는 사실이 널리 인식됨에 따라, 이 시장은 큰 성장세를 보이고 있습니다.
케타민 전문 클리닉의 설립은 특히 기존의 항우울제나 통증 관리 요법에 반응이 없는 환자를 대상으로 한 대체 치료법에 대한 수요 증가에 대응하기 위한 방안으로 대두되었습니다. 이 시장에는 독립형 케타민 클리닉, 병원 내 케타민 치료 센터, 통합형 정신건강 시설 등 다양한 서비스 제공 모델이 포함되어 있습니다. 케타민 투여를 둘러싼 규제 환경은 크게 변화하고 있으며, 미국 FDA의 에스케타민(Spravato) 비강 스프레이 승인은 케타민 기반 치료법의 정당성을 한층 더 높여, 임상 현장에서의 도입 확대와 환자의 수용을 통해 시장 성장을 뒷받침하고 있습니다.
시장 역학
세계 케타민 클리닉 시장은 몇 가지 주요 시장 성장 촉진요인에 의해 주도되고 있습니다. 그 중 하나는 전 세계적으로 증가하고 있는 치료 저항성 우울증 및 정신 질환의 유병률입니다. 우울증 환자의 약 30%가 기존의 항우울제에 반응하지 않아, 대체 치료법에 대한 수요가 크게 증가하고 있습니다. 또한, 의료 종사자와 환자들 사이에서 케타민의 즉각적인 항우울 효과에 대한 인식이 높아지고 있는 점도 시장 도입을 크게 촉진하고 있습니다. 케타민은 몇 주가 아니라 몇 시간 이내에 호전되는 경우가 많기 때문입니다. 또한, 다양한 신경정신과 질환에 대한 효능을 입증하는 광범위한 임상 연구에 힘입어 의료계에서 케타민 치료법에 대한 수용도가 높아지고 있는 점도 시장 성장을 더욱 가속화하고 있습니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 예를 들어, 치료비가 고액이기 때문에 많은 환자가 이용하기 어려운 점입니다. 케타민 치료 세션은 보통 1회당 400-800달러 정도이지만, 보험이 적용되지 않는 경우가 많기 때문입니다.
케타민의 적응증 외 사용과 관련된 규제상의 복잡성과 투여 중 전문적인 의료 감독 요건은 진료소 운영에 있어 실무상의 과제가 되고 있습니다. 또한, 케타민의 남용 위험과 해리 작용에 대한 안전성 우려, 그리고 환자에 대한 세심한 모니터링의 필요성 또한 시장 성장의 제약 요인으로 작용하고 있습니다. 이러한 과제가 있음에도 불구하고, 의료 서비스가 미치지 않는 지역으로 시장 확대, 표준화된 치료 프로토콜 개발, 그리고 환자 모니터링 강화를 목적으로 한 디지털 헬스 플랫폼과의 케타민 치료 통합 등 큰 기회가 존재합니다. 케타민과 심리치료 및 기타 약물을 결합한 병용 요법의 가능성은 향후 성장의 길을 제시하고 있으며, 한편 새로운 케타민 제제 및 투여법에 대한 지속적인 연구는 대상 시장을 더욱 확대하고 치료 성과를 향상시킬 가능성이 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 케타민 클리닉 시장의 주요 기업 프로파일을 분석했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 케타민 클리닉 시장에 대한 분석으로, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 케타민 클리닉 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 케타민 클리닉 시장 : 치료법별, 2021년-2033년
제5장 세계의 케타민 클리닉 시장 : 적응증별, 2021년-2033년
제6장 세계의 케타민 클리닉 시장 : 투여 경로별, 2021년-2033년
제7장 세계의 케타민 클리닉 시장 : 환자 연령층별, 2021년-2033년
제8장 세계의 케타민 클리닉 시장 : 케어 유형별, 2021년-2033년
제9장 세계의 케타민 클리닉 시장 : 소개 채널별, 2021년-2033년
제10장 세계의 케타민 클리닉 시장 : 비즈니스 모델별, 2021년-2033년
제11장 세계의 케타민 클리닉 시장 : 지역별, 2021년-2033년
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 조사 방법
LSH 26.06.22Ketamine Clinic Market is estimated to be valued at USD 1.60 Bn in 2026 and is expected to reach USD 3.42 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.60 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.40% | 2033 Value Projection: | USD 3.42 Bn |
The global ketamine clinic market represents a rapidly evolving segment within the mental health and pain management healthcare landscape, characterized by specialized medical facilities that administer ketamine-based treatments for various therapeutic applications. These clinics primarily focus on providing ketamine infusion therapy for treatment-resistant depression, chronic pain conditions, Post-Traumatic Stress Disorder (PTSD), anxiety disorders, and other neuropsychiatric conditions where traditional treatments have proven inadequate. The market has gained significant momentum due to the growing recognition of ketamine's unique mechanism of action as an N-methyl-D-aspartate (NMDA) receptor antagonist, which offers rapid-onset antidepressant effects and analgesic properties.
The establishment of dedicated ketamine clinics has emerged as a response to the increasing demand for alternative treatment modalities, particularly for patients who have not responded to conventional antidepressants or pain management therapies. This market encompasses various service delivery models, including standalone ketamine clinics, hospital-based ketamine treatment centers, and integrated mental health facilities. The regulatory landscape surrounding ketamine administration has evolved significantly, with the U.S. FDA approval of esketamine (Spravato) nasal spray further legitimizing ketamine-based treatments and driving market expansion through increased clinical adoption and patient acceptance.
Market Dynamics
The global ketamine clinic market is propelled by several key drivers, including the rising prevalence of treatment-resistant depression and mental health disorders worldwide, with approximately 30% of depression patients not responding to traditional antidepressants, creating substantial demand for alternative therapeutic interventions. The growing awareness among healthcare professionals and patients about ketamine's rapid-acting antidepressant properties, often showing improvement within hours rather than weeks, significantly drives market adoption. Additionally, the increasing acceptance of ketamine therapy by medical communities, supported by extensive clinical research demonstrating efficacy in various neuropsychiatric conditions, further accelerates market growth. However, the market faces notable restraints, including high treatment costs that limit accessibility for many patients, as ketamine therapy sessions typically range from USD 400-800 per treatment and are often not covered by insurance providers.
Regulatory complexities surrounding off-label ketamine use and the requirement for specialized medical supervision during administration create operational challenges for clinic establishments. Safety concerns related to ketamine's potential for abuse, dissociative effects, and the need for careful patient monitoring also pose market limitations. Despite these challenges, significant opportunities exist in the market expansion into underserved geographical regions, development of standardized treatment protocols, and integration of ketamine therapy with digital health platforms for enhanced patient monitoring. The potential for combination therapies incorporating ketamine with psychotherapy or other medications presents additional growth avenues, while ongoing research into novel ketamine formulations and delivery methods could further expand the addressable market and improve treatment outcomes.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global ketamine clinic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Mindbloom Inc., Mindful Health Solutions, Field Trip Health, Nushama Psychedelic Wellness Center, Klarisana, Revitalist Lifestyle and Wellness, Ketamine Clinics Los Angeles, Actify Neurotherapies, Ember Health, Bloom Mental Health, Joyous, HealingMaps Ketamine Network, Klarity Clinic, The Stella Center, NY Ketamine Infusions, and MindPeace Clinics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global ketamine clinic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ketamine clinic market
Market Segmentation
- Therapy Modality Insights (Revenue, USD Bn, 2021 - 2033)
- On-Site/In-Clinic Therapy
- Online Ketamine Therapy Consultation Services/Telehealth Therapy
- Clinical Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Treatment-resistant unipolar depression
- Major depressive disorder with acute suicidal ideation/behavior
- Bipolar depression
- Post-traumatic stress disorder
- Anxiety disorders
- Obsessive-compulsive disorder
- Substance use disorders (e.g., AUD)
- Neuropathic pain (e.g., CRPS, diabetic neuropathy)
- Chronic musculoskeletal pain (e.g., low back/osteoarthritis)
- Fibromyalgia
- Migraine/headache disorders
- Cancer-related/palliative pain
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Parenteral
- Nasal
- Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Adolescents (13-17)
- Adults (18-64)
- Geriatric (65+)
- Care Type Insights (Revenue, USD Bn, 2021 - 2033)
- Medication-only
- Ketamine-assisted psychotherapy
- Referral Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Direct-to-consumer or self-referred
- Physician-referred (psychiatry/primary care)
- Payer/case-management referred
- Business Model Insights (Revenue, USD Bn, 2021 - 2033)
- Independently owned private clinic
- Franchise-Owned clinics
- Hospital affiliated clinics
- Research and Clinical Trial Centers
- Others (Anesthesiology/psychology practice extension)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Mindbloom Inc.
- Mindful Health Solutions
- Field Trip Health
- Nushama Psychedelic Wellness Center
- Klarisana
- Revitalist Lifestyle and Wellness
- Ketamine Clinics Los Angeles
- Actify Neurotherapies
- Ember Health
- Bloom Mental Health
- Joyous
- HealingMaps Ketamine Network
- Klarity Clinic
- The Stella Center
- NY Ketamine Infusions
- MindPeace Clinics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Ketamine Clinic Market, By Therapy Modality
- Global Ketamine Clinic Market, By Clinical Indication
- Global Ketamine Clinic Market, By Route of Administration
- Global Ketamine Clinic Market, By Patient Age Group
- Global Ketamine Clinic Market, By Care Type
- Global Ketamine Clinic Market, By Referral Channel
- Global Ketamine Clinic Market, By Business Model
- Global Ketamine Clinic Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Ketamine Clinic Market, By Therapy Modality, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- On-Site/In-Clinic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Ketamine Therapy Consultation Services/Telehealth Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Ketamine Clinic Market, By Clinical Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Treatment-resistant unipolar depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Major depressive disorder with acute suicidal ideation/behavior
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bipolar depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Post-traumatic stress disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Anxiety disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Obsessive-compulsive disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Substance use disorders (e.g., AUD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neuropathic pain (e.g., CRPS, diabetic neuropathy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic musculoskeletal pain (e.g., low back/osteoarthritis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fibromyalgia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Migraine/headache disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cancer-related/palliative pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Ketamine Clinic Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Ketamine Clinic Market, By Patient Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adolescents (13-17)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adults (18-64)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric (65+)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Ketamine Clinic Market, By Care Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Medication-only
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ketamine-assisted psychotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Ketamine Clinic Market, By Referral Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Direct-to-consumer or self-referred
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Physician-referred (psychiatry/primary care)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Payer/case-management referred
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Ketamine Clinic Market, By Business Model, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Independently owned private clinic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Franchise-Owned clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospital affiliated clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Clinical Trial Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Anesthesiology/psychology practice extension)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Ketamine Clinic Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapy Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapy Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapy Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapy Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapy Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Clinical Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Care Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Referral Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Business Model, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Mindbloom Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindful Health Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Field Trip Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nushama Psychedelic Wellness Center
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Klarisana
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revitalist Lifestyle and Wellness
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ketamine Clinics Los Angeles
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Actify Neurotherapies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ember Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bloom Mental Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Joyous
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HealingMaps Ketamine Network
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Klarity Clinic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- The Stella Center
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NY Ketamine Infusions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MindPeace Clinics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About Us
